Percutaneous Absorption in Man: In vitro-in vivo Correlation

被引:97
作者
Lehman, P. A. [1 ]
Raney, S. G. [1 ]
Franz, T. J. [1 ]
机构
[1] Cetero Res, Preclin Dermatol, Fargo, ND USA
关键词
Percutaneous absorption; In vitro-in vivo correlation; Bioavailability; Bioequivalence; HUMAN VOLUNTEERS; DERMAL ABSORPTION; FLUAZIFOP-BUTYL; SKIN ABSORPTION; BENZOIC-ACID; PENETRATION; INVITRO; INVIVO; RAT; PHARMACOKINETICS;
D O I
10.1159/000324884
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Aims: To examine the existing literature to determine the degree to which percutaneous absorption data obtained using the excised human skin model match those obtained from living man. Methods: The scientific literature was reviewed to collect data on compounds whose percutaneous absorption through human skin had been measured under both in vitro and in vivo conditions. The in vitro-in vivo (IVIV) correlation was evaluated by computing the in vitro/in vivo ratio using total absorption (percent of applied dose) as the metric for comparison. Results: A total of 92 data sets were collected from 30 published studies. The average IVIV ratio across all values was 1.6, though for any single data set there could be a nearly 20-fold difference between the in vitro and in vivo values. In 85% of the cases, however, the difference was less than 3-fold. The correlation was significantly improved when data were excluded from studies in which the protocols for both studies were not fully harmonized. For harmonized data sets the average IVIV ratio was 0.96 and there was a less than 2-fold difference between the in vitro and in vivo results for any one compound, with IVIV ratios ranging from 0.58 to 1.28. The dominant factors leading to exclusion of data were the use of skin from different anatomical sites and vehicles of differing composition. Conclusions: Percutaneous absorption data obtained from the excised human skin model closely approximate those obtained from living man when the two study protocols are appropriately matched. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:224 / 230
页数:7
相关论文
共 41 条
[1]   INFLUENCE OF VEHICLES ON SKIN PENETRATION [J].
BARRETT, CW ;
SARKANY, I ;
HADGRAFT, JW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1964, 16 :T104-&
[2]   Comparative in vitro skin absorption and metabolism of coumarin (1,2-benzopyrone) in human, rat, and mouse [J].
BeckleyKartey, SAJ ;
Hotchkiss, SAM ;
Capel, M .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 145 (01) :34-42
[3]   Percutaneous absorption of Mexoryl SX® in human volunteers:: Comparison with in vitro data [J].
Benech-Kieffer, F ;
Meuling, WJA ;
Leclerc, C ;
Roza, L ;
Leclaire, J ;
Nohynek, G .
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 2003, 16 (06) :343-355
[4]   PERCUTANEOUS-ABSORPTION OF NITROAROMATIC COMPOUNDS - INVIVO AND INVITRO STUDIES IN THE HUMAN AND MONKEY [J].
BRONAUGH, RL ;
MAIBACH, HI .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1985, 84 (03) :180-183
[5]   METHODS FOR INVITRO PERCUTANEOUS-ABSORPTION STUDIES .3. HYDROPHOBIC COMPOUNDS [J].
BRONAUGH, RL ;
STEWART, RF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (09) :1255-1258
[6]   VEHICLE EFFECTS ON PERCUTANEOUS-ABSORPTION - INVIVO AND INVITRO COMPARISONS WITH HUMAN-SKIN [J].
BRONAUGH, RL ;
FRANZ, TJ .
BRITISH JOURNAL OF DERMATOLOGY, 1986, 115 (01) :1-11
[7]   PERCUTANEOUS PENETRATION AND MASS BALANCE ACCOUNTABILITY - TECHNIQUE AND IMPLICATIONS FOR DERMATOLOGY [J].
BUCKS, DAW ;
GUY, RH ;
MAIBACH, HI .
JOURNAL OF TOXICOLOGY-CUTANEOUS AND OCULAR TOXICOLOGY, 1989, 8 (04) :439-451
[8]   BIOAVAILABILITY OF TOPICALLY ADMINISTERED STEROIDS - A MASS BALANCE TECHNIQUE [J].
BUCKS, DAW ;
MCMASTER, JR ;
MAIBACH, HI ;
GUY, RH .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 91 (01) :29-33
[9]   ORAL AND DERMAL PHARMACOKINETICS OF TRICLOPYR IN HUMAN VOLUNTEERS [J].
CARMICHAEL, NG ;
NOLAN, RJ ;
PERKINS, JM ;
DAVIES, R ;
WARRINGTON, SJ .
HUMAN TOXICOLOGY, 1989, 8 (06) :431-437
[10]   Comparative in vitro-in vivo percutaneous penetration of the fungicide ortho-phenylphenol [J].
Cnubben, NHP ;
Elliott, GR ;
Hakkert, BC ;
Meuling, WJA ;
van de Sandt, JJM .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2002, 35 (02) :198-208